Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mathiot

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 1, 1995
Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantationE Clave, G Socié, J M Cosset, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phenotypic and functional analysis of tumour-infiltrating lymphocytes from patients with melanoma and other metastatic cancersC Mathiot, E Robin, A Gey, et al.
Journal D'Urologie|January 1, 1994
[CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study]N Thiounn, C Mathiot, T Flam, et al.
Leukemia Research|January 1, 1991
Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patientsC Billard, D Ferbus, R A Diez, et al.
Biotechnology Therapeutics|January 1, 1992
IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parametersT Dorval, C Mathiot, O Chosidow, et al.
AIDS Research and Human Retroviruses|September 1, 1996
Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtypingF Barin, Y Lahbabi, L Buzelay, et al.
La Revue De Medecine Interne|January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]C Mathiot, B Grosbois, J L Teillaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsJ-Y Pierga, D Hajage, T Bachelot, et al.
Journal of Clinical Immunology|January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myelomaC Mathiot, J L Teillaud, M Elmalek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Characteristics of serogroup A Neisseria meningitidis strains isolated in the Central African Republic in February 1992M Guibourdenche, D A Caugant, V Hervé, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|November 1, 1995
Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantationE Clave, G Socié, J M Cosset, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phenotypic and functional analysis of tumour-infiltrating lymphocytes from patients with melanoma and other metastatic cancersC Mathiot, E Robin, A Gey, et al.
Journal D'Urologie|January 1, 1994
[CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study]N Thiounn, C Mathiot, T Flam, et al.
Leukemia Research|January 1, 1991
Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: lack of in vivo down-regulation and reduced affinity of IFN-alpha receptors in unresponsive patientsC Billard, D Ferbus, R A Diez, et al.
Biotechnology Therapeutics|January 1, 1992
IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parametersT Dorval, C Mathiot, O Chosidow, et al.
AIDS Research and Human Retroviruses|September 1, 1996
Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtypingF Barin, Y Lahbabi, L Buzelay, et al.
La Revue De Medecine Interne|January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]C Mathiot, B Grosbois, J L Teillaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsJ-Y Pierga, D Hajage, T Bachelot, et al.
Journal of Clinical Immunology|January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myelomaC Mathiot, J L Teillaud, M Elmalek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Characteristics of serogroup A Neisseria meningitidis strains isolated in the Central African Republic in February 1992M Guibourdenche, D A Caugant, V Hervé, et al.
Pageof 9